Hangzhou, China

Kai Dong

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kai Dong. Retrieved from https://idiyas.com/inventor/kai-dong-t132soyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.5

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kai Dong

Introduction

Kai Dong is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in vaccine development. With a total of 2 patents, his work is paving the way for advancements in medical science.

Latest Patents

Kai Dong's latest patents include the "Respiratory Syncytial Virus mRNA Vaccine, and Preparation Method Therefor and Use Thereof" and the "Herpes Zoster mRNA Vaccine, Preparation Method Therefor, and Use Thereof." These innovations are crucial in addressing viral infections and improving public health.

Career Highlights

He is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd., where he continues to focus on groundbreaking research and development in the pharmaceutical industry. His work is instrumental in the ongoing fight against infectious diseases.

Collaborations

Kai Dong collaborates with talented individuals such as Gengshen Song and Yuting Zhou, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Kai Dong's contributions to vaccine development highlight his role as a key inventor in the pharmaceutical field. His innovative work is essential for advancing healthcare solutions and combating viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…